BNET Industries
Market Cap:$269.9M
Last Fiscal Year Sales:$91.8M
- Public
Dow Jones Description
Comet Technologies, Inc. (the "Company" or "Comet") is a "blank check" company which has been seeking to locate a business enterprise which it may acquire, merge or reorganize with, or become engaged in. The Company has been inactive for several years, and until January, 2004, when it entered into an agreement with Town House Land Limited, discussed below, had not located any specific business enterprise for its involvement, nor had it entered into any arrangement or agreements with respect thereto. Since the completion of the Company's public offering in August 1986, the Company has reviewed and evaluated numerous business ventures for possible acquisition or participation by the Company. To date, the Company has not acquired any business venture or engaged in any active operations. The Company was inactive until January, 2004, when the Company entered into a Stock Exchange Agreement (the "Exchange Agreement") with Town House Land Limited ("Town House"), a company organized in the Hong Kong Special Administrative Region in The People's Republic of China, and the shareholders of Town House, providing for the acquisition of Town House in a reverse acquisition.
Chief Financial Officer
Han XiaoNumber of Employees 1,804
Contact Information
No. 38 Dingxin 3rd Street
Nangang District, Heilongjiang Province
Harbin 150001
213-488-5131
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
China Sky One Nears Approval on Two Diagnostic Tests
-
Gentium loses CEO, board
News & Analysis
Filter by
china and china sky one medical inc. - All News and Analysis
China Sky One Nears Approval on Two Diagnostic Tests
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) said it expects to have final SFDA approval for two more diagnostic kits by the end of 2009. One is a diagnostic test for Human Prostate Specific Antigen, an indicator of prostate related diseases, and the other is a determination...
China Sky's Financial Statements: Huge Discrepancies
On August 6th, we first reported on discrepancies between the financial statements of China Sky One Medical, Inc. CSKI filed with U.S. and Chinese regulatory agencies. CSKI files consolidated financial statements with the U.S. Securities and Exchange Commission (SEC), and CSKI's operating subsidiaries, all located in China, file financial...
China Sky's Financial Irregularities Continue in Third Quarter Earnings
China Sky One Medical, Inc. CSKI released its third-quarter earnings on November 17, 2009. The financial irregularities that asensio.com began reporting on in April 2009 continued to be evident in CSKI’s third-quarter financial statements. China Sky continues to report a questionably low inventory level. asensio.com compared CSKI to...
China Sky One Expands Patch Distribution into Canada
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) has begun exporting its Pain Relief patch to Canada. Because the product is based on a traditional Chinese herbal formulation, it did not have to undergo clinical trials before going on sale. The company said the first order was for...
China Sky One Admits Under-Reported Revenue
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) (??????????) admitted that its financial reports filed with the State Administration for Industry and Commerce (SAIC) under-reported the income of China Sky One’s China-based subsidiaries. The company said it expects the SAIC to assess a penalty for the misstatements, but...
China Sky One Reports Record Results for Q2
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported record high results for Q2 of 2009, and the company reiterated its guidance for full-year 2009. During the second quarter, revenue climbed 36% to $32.2 million, while net income rose 17% to $9.5 million, or 57 cents per share,...
Three Beneficiaries of China's Healthcare Reform
China’s unprecedented economic growth during the past decade has generated incredible wealth, but the country’s population is also demanding a higher standard of living. As the result, the government plans to spend some $124 billion over the next three years to provide accessible and affordable healthcare to the country’s 1.3...
China Sky One May Raise New Capital for Acquisitions
ChinaBio Today submits: China Sky One Medical Inc, (NSDQ: CSKI) is considering raising funds to finance acquisitions. The company’s primary goal will be to acquire new products, instead of whole brands or entire companies, according to CEO Liu Yanqing who was quoted in a Reuters article. Liu said...
China Sky One Wins Good Manufacturing Practices Renewal
ChinaBio Today submits: China Sky One Medical (NSDQ: CSKI) reported that its new Peng Lai Jin Chuang Pharmaceutical Company subsidiary received an SFDA renewal of its Good Manufacturing Practices Certificate. The certificate is good for five years.China Sky One closed its purchase of Jin Chuang in September 2008. For...
China Sky's Weight-Loss Patch Has a Questionable Future
China Sky One Medical, Inc. CSKI states in its 10-K that its weight-loss patch product, the Sumei Slim Patch, is "believed to foster weight loss and prevent weight gain." The Sumei Slim Patch comprised 22% of China Sky's total sales in 2008, according to the company's fourth quarter earnings...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Han Xiao | Chief Financial Officer |
| Han Xiao-Yan | Principal Financial Officer and Director |
| Wen Chao Zhang | Director of Scientific and Technological Development |
Ms. Han had five years of hygiene and medical media experience before joining TDR. She has been instrumental in developing and marketing TDR’s products and expanding its sales. She serves as a senior marketing manager and administrative manager and has 10 years of financial management experience. In 2004, she was appointed the general manager of TDR, with responsibility for financing, production, quality control and purchasing. In 2003, she was appointed director of Harbin First Bio-Engineering. She received Master of Business Administration at Harbin Industrial University in 2004. Ms. Han Xiao-yan owns 1,406,717 shares, 8.9% of outstanding shares.
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Principal Financial Officer and Director | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Director of Scientific and Technological Development | Current |
| Volume | 116,145 |
| Shares Outstanding | 16.6M |
| Market Cap | 269.9M |
| Year High | 19.11 |
| Year Low | 8.56 |
| Earnings Per Share | 2.19 |
| P/E Ratio | 7.3973 |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


